Latest Breaking News On - Johnson johnston assocs inc - Page 1 : comparemela.com

In Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc., the Federal Circuit issued a Rule 36 opinion affirming the Patent Trial and Appeal Board’s PTAB’s Final Written Decision FWD holding all challenged claims unpatentable.

United statesTeva pharmsToro coInstitution decisionOcular therapeutix incUnited states incFoxconn intl incJohnson johnston assocs incMati therapeutics incHindus incSee pfizer incCo incMati therapeuticsFederal circuitPatent trialAppeal board